HOME >> BIOLOGY >> NEWS
Classical subject underpins new biomedical advances

The ancient art of physiology -- the study of how the body works and how to repair it when things go wrong--has seen an upsurge in importance as it now plays a key role in the understanding of how genes work to support the human body.

At his inaugural lecture on Thursday (17 March), University of Edinburgh Professor Michael J. Shipston will say that our ability to isolate, manipulate and visualise gene products in cells and whole animals has revolutionized the understanding of the body and its functions. This in turn has caused a rise in demand for scientists with physiological training, to fully exploit these advances.

He will say: "This classical subject was described by Aristotle as the study of the whole organism and its component parts. It is now at the forefront of current biomedical advances as it seeks to understand how the catalogue of our genes, the human genome, is exploited to generate and maintain the human body."

Michael J. Shipston, Professor of Physiology and Director of the Centre for Integrative Physiology at the University, will discuss the importance of communication within and between cells of the body, in order to keep its 30kg of cells warm, fed and able to reproduce in 20 litres of water. To achieve this, cells need to overcome a major paradox -- the transfer of information, nutrients and waste products across fatty cell membranes which are designed to limit the transfer of these important molecules in order to keep the cell's environment separate from that of its neighbours.

He will say that art influences his approach to science, as by visualising the body's life processes, such as cells releasing hormones or single molecules in motion, he is able to obtain new insights into the basic processes which make the body work.

Physiology and the Art of Communication by Professor Michael Shipston, College of Medicine and Veterinary Medicine, University of Edinburgh: Thursday, 17 March 2005 in the Anatomy Lec
'"/>

Contact: Linda Menzies
linda.menzies@ed.ac.uk
44-131-650-6382
University of Edinburgh
16-Mar-2005


Page: 1 2

Related biology news :

1. Pavlovs cockroach: Classical conditioning of salivation in an insect
2. A prickly subject: The sea urchin genome is sequenced
3. Fruit flies aboard space shuttle subjects of UCF, UC Davis study on immunity and space
4. Student work in human subjects protection sought for FDA conference at UH
5. New proteomics research promises to revolutionize biomedical discovery
6. Bee researcher at Arizona State University is 1 of 20 new Pew Scholars in the biomedical sciences
7. Methodist, University of Houston, Cornell combine biomedical imaging expertise
8. Research center unites biomedical competitors to fund medical technology development
9. UT Metroplex institutions to collaborate on biomedical research
10. APS President-Elect Carey urges 6.7 percent increase for biomedical research
11. Polymers show promise for gene delivery, tissue scaffolds, other biomedical applications

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Classical subject underpins new biomedical advances

(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/25/2015)... -- According to a new market ... Technology, Material (Optical Prism, Piezoelectric, Capacitive & Adhesives), ... & Geography - Global Forecast to 2014 - ... expected to reach $14,500.07 Million by 2020, at ... 76 market Tables and 109 Figures spread through ...
(Date:6/24/2015)... YORK , June 24, 2015 The ... rate. The major drivers for the market include growth ... number of new drug launches. Over the years, the ... increased. Between 2001 and 2010, the FDA approved 225 ... according to WIPO, Europe accounted ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
(Date:7/1/2015)... 2015   Decision Resources Group finds ... Otezla are its oral administration, alternative mechanism of ... surveyed rheumatologists. Otezla was the first oral therapy ... active psoriatic arthritis in the United ... includes conventional oral treatments including disease-modifying antirheumatic drugs ...
(Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
(Date:7/1/2015)... 1, 2015  Axovant Sciences Ltd. (NYSE:  AXON), ... treatment of dementia, today announced that the company ... at 5:45 p.m. EDT following its presentation of ... Conference 2015 (AAIC). The event ... Dr. Lawrence Friedhoff , Chief Development Officer, ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan contest will ask ... to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will ... and a period of expert mentorship from a senior industry figure drawn from the ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: